Cases 1 - 10 of 147
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2025cv11924
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Otsuka America Pharmaceutical, Inc. et al v. Hetero Labs Limited et al
as 1:2025cv00647
Plaintiff:
Avanir Pharmaceuticals, LLC, Otsuka America Pharmaceutical, Inc. and Avanir Pharmaceuticals, Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Ltd. Unit-III and Camber Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AVEO Pharmaceuticals, Inc. v. Hetero USA Inc. et al
as 1:2025cv00639
Plaintiff:
AVEO Pharmaceuticals, Inc.
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Hetero Labs Limited et al
as 1:2025cv00625
Plaintiff:
AbbVie Inc., AbbVie Ltd and Neurocrine Biosciences, Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PHARMACOSMOS A/S et al v. HETERO LABS LIMITED et al
as 2:2025cv03945
Plaintiff:
PHARMACOSMOS A/S, PHARMACOSMOS HOLDING A/S and PHARMACOSMOS THERAPEUTICS INC.
Defendant:
HETERO LABS LIMITED, HETERO USA, INC. and HETERO LABS LIMITED UNIT-VI
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Hetero Labs Limited et al v. AbbVie Inc. et al
as 1:2025cv00431
Plaintiff:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Defendant:
AbbVie Inc. and Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Urovant Sciences GmbH et al v. Annora Pharma Private Limited et al
as 1:2025cv00419
Plaintiff:
Urovant Sciences GmbH and Sumitomo Pharma America, Inc.
Defendant:
Annora Pharma Private Limited, Hetero USA Inc., Hetero Labs Limited and others
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Sumitomo Pharma Switzerland GmbH et al v. Annora Pharma Private Limited et al
as 1:2025cv00380
Plaintiff:
Sumitomo Pharma Switzerland GmbH, Sumitomo Pharma America, Inc., Takeda Pharmaceutical Company Limited and others
Defendant:
Annora Pharma Private Limited, Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Sumitomo Pharma Switzerland GmbH et al v. Hetero Labs Limited et al
as 1:2025cv00344
Plaintiff:
Sumitomo Pharma Switzerland GmbH, Sumitomo Pharma America, Inc., Takeda Pharmaceutical Company Limited and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc. and others
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
BioCryst Pharmaceuticals, Inc. v. Annora Pharma Private Limited et al
as 1:2025cv00281
Plaintiff:
BioCryst Pharmaceuticals, Inc.
Defendant:
Annora Pharma Private Limited, Hetero USA, Inc., Hetero Labs Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
